ICH Q3E : How the new guideline reshapes your Extractables & Leachables (E&L) studies
📃 ICH Q3E is set to reshape how Extractables & Leachables (E&L) studies are designed and controlled. Released as a draft in August 2025,...
📃 Since 2019, the regulatory framework on nitrosamines in pharmaceutical products has kept evolving. Systematic risk evaluation, confirmatory testing, marketing authorization variations, lifecycle management : the ICH M7 guidelines have progressively expanded these requirements for manufacturers. But beyond the regulatory text, the real challenge is analytical : detecting genotoxic impurities down to 18 ng/day (CPCA […]